Citation Impact
Citing Papers
High Basal Nuclear Levels of Nrf2 in Acute Myeloid Leukemia Reduces Sensitivity to Proteasome Inhibitors
2011
Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
2006
The Potential Role of Curcumin in Patients with Monoclonal Gammopathy of Undefined Significance—Its Effect on Paraproteinemia and the Urinary N-Telopeptide of Type I Collagen Bone Turnover Marker
2009
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
2008 StandoutScience
Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia
2011
The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3
2010
Safety and Anti-Inflammatory Activity of Curcumin: A Component of Tumeric ( Curcuma longa )
2003 Standout
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells
2003
Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
2009 Standout
Analgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2015
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
2010
Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy
2007
Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial
2013
The multifaceted role of Nrf2 in mitochondrial function
2016
Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and their Pharmacodynamic Consequences
2005
The Role of Tumor Necrosis Factor α in Down-Regulation of Osteoblast Phex Gene Expression in Experimental Murine Colitis
2006
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study
2014
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
2015
Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface
2002
Novel Therapeutic Approach for the Treatment of Periodontitis by Curcumin
2014
Regulation of heme oxygenase-1 expression by demethoxy curcuminoids through Nrf2 by a PI3-kinase/Akt-mediated pathway in mouse β-cells
2007
Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin
2002
Targeting hypoxia in cancer therapy
2011 Standout
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation
2001 Standout
Cancer chemoprevention with dietary phytochemicals
2003 Standout
Effect of azoxymethane and curcumin on transcriptional levels of cyclooxygenase-1 and -2 during initiation of colon carcinogenesis
2006
NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps
2001
Single-cell spatial reconstruction reveals global division of labour in the mammalian liver
2017 Nature
Activation of PPARγ by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR
2004
Modulation of arachidonic acid metabolism by curcumin and related -diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase
2004
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles
2011
Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials
2007 Standout
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
2012 Standout
Helicobacter pylori-induced Expression of Interleukin-8 and Cyclooxygenase-2 in AGS Gastric Epithelial Cells: Mediation by Nuclear Factor-κB
2001
Anticancer and carcinogenic properties of curcumin: Considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent
2008
Curcumin (Diferuloylmethane) Down-Regulates Expression of Cell Proliferation and Antiapoptotic and Metastatic Gene Products through Suppression of IκBα Kinase and Akt Activation
2005
Curcumin impairs tumor suppressor p53 function in colon cancer cells
2004
Curcumin for chemoprevention of colon cancer
2007
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial
2008
Automated synthesis of oligosaccharides as a basis for drug discovery
2005
Identification of aldo-keto reductases as NRF2-target marker genes in human cells
2013
Curcumin, a component of turmeric: From farm to pharmacy
2013
“Spicing Up” of the Immune System by Curcumin
2007
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
2012
HIGHLY ACTIVE ANTICANCER CURCUMIN ANALOGUES
2007
NRF2 and the Hallmarks of Cancer
2018
Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study
2005
Studies on the in vitro absorption of spice principles – Curcumin, capsaicin and piperine in rat intestines
2007
Curcumin enhances dasatinib‐induced inhibition of growth and transformation of colon cancer cells
2010
Unraveling Curcumin Degradation
2015
Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma
2005
Esophageal Cancer
2003 Standout
Prevention of liver cirrhosis in rats by curcumin
2007
Curcumin as “Curecumin”: From kitchen to clinic
2007 Standout
Curcumin prevents and ameliorates trinitrobenzene sulfonic acid–induced colitis in mice
2002
Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice
2005
Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology
2001
Inhibition of the SERCA Ca2+ pumps by curcumin
2001
Curcumin inhibition of bleomycin‐induced pulmonary fibrosis in rats
2000
Curcumin Induces Apoptosis in Human Melanoma Cells through a Fas Receptor/Caspase-8 Pathway Independent of p53
2001
Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3
2004
Cellular and molecular parameters of mesothelioma
2006
Metal-mediated DNA damage induced by curcumin in the presence of human cytochrome P450 isozymes
2002
A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients
2013
Cancer Cell Signaling Pathways Targeted by Spice-Derived Nutraceuticals
2011
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
2010
The cytoprotective role of the Keap1–Nrf2 pathway
2011
Dose escalation of a curcuminoid formulation
2006 Standout
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor‐κB signaling
2004
The Keap1–Nrf2 system in cancers: stress response and anabolic metabolism
2012
Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
2004 Standout
β-Catenin-mediated transactivation and cell–cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells
2002
Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF- B activation
2003
Curcumin as a therapeutic agent: the evidence fromin vitro, animal and human studies
2010
Curcumin: The story so far
2005 Standout
An efficient and sensitive method for preparing cDNA libraries from scarce biological samples
2014 StandoutNobel
Inhibition of Colonic Aberrant Crypt Foci by Curcumin in Rats Is Affected by Age
2004
Curcumin, a component of golden spice: From bedside to bench and back
2014
Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines
2001
High‐performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin
2007
Evaluation of Resveratrol, Green Tea Extract, Curcumin, Oxaloacetic Acid, and Medium-Chain Triglyceride Oil on Life Span of Genetically Heterogeneous Mice
2012
PHARMACOKINETICS AND PHARMACODYNAMICS OF CURCUMIN
2007
Evidence That Curcumin Suppresses the Growth of Malignant Gliomas in Vitro and in Vivo through Induction of Autophagy: Role of Akt and Extracellular Signal-Regulated Kinase Signaling Pathways
2007
MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis
2013
Iron chelation in the biological activity of curcumin
2005
Osteoclast differentiation and activation
2003 StandoutNature
Inhibition by dietary dibenzoylmethane of mammary gland proliferation, formation of DMBA–DNA adducts in mammary glands, and mammary tumorigenesis in Sencar mice
2001
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
2010
The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention
2015
Change in post‐translational modifications of histone H3, heat‐shock protein‐27 and MAP kinase p38 expression by curcumin in streptozotocin‐induced type I diabetic nephropathy
2008
Translational medicine: targetting cyclo-oxygenase isozymes to prevent cancer
2002
Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa
2010
Oxidative Stress in Cancer
2020 Standout
Curcumin Blocks Interleukin-1 (IL-1) Signaling by Inhibiting the Recruitment of the IL-1 Receptor–Associated Kinase IRAK in Murine Thymoma EL-4 Cells
2005
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
2014 Standout
Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
2000
The Molecular Basis for the Pharmacokinetics and Pharmacodynamics of Curcumin and Its Metabolites in Relation to Cancer
2013
Curcumin for Radiation Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Thirty Breast Cancer Patients
2013
Curcumin Inhibits Hypoxia-Inducible Factor-1 by Degrading Aryl Hydrocarbon Receptor Nuclear Translocator: A Mechanism of Tumor Growth Inhibition
2006
Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid‐induced colitis
2003
Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl
2002
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
2012 Standout
NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach
2003
AberrantKeap1methylation in breast cancer and association with clinicopathological features
2012
Nuclear factor‐κB and IκB kinase are constitutively active in human pancreatic cells, and their down‐regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis
2004
Bisdemethylcurcumin and structurally related hispolon analogues of curcumin exhibit enhanced prooxidant, anti-proliferative and anti-inflammatory activities in vitro
2010
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration
2004
Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins
2008
Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation
2002
Immediate and Delayed Treatments with Curcumin Prevents Forebrain Ischemia-Induced Neuronal Damage and Oxidative Insult in the Rat Hippocampus
2006
Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?
2009
Glucuronidation of curcuminoids by human microsomal and recombinant UDP‐glucuronosyltransferases
2007
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Biological Properties of Curcumin-Cellular and Molecular Mechanisms of Action
2004
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Effectiveness of sub gingival irrigation of an indigenous 1% curcumin solution on clinical and microbiological parameters in chronic periodontitis patients: A pilot randomized clinical trial
2013
Epigenetic changes induced by curcumin and other natural compounds
2011
Impact of Nrf2 on UVB‐induced skin inflammation/photoprotection and photoprotective effect of sulforaphane
2010
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
The Hallmarks of Aging
2013 Standout
Role of plant polyphenols in genomic stability
2001
Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer
2011
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
2010 Standout
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Cancer chemoprevention by dietary constituents: a tale of failure and promise
2001
Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells
2003
Cyclooxygenase isozymes and their gene structures and expression
2002
Laser Capture Microdissection of Embryonic Cells and Preparation of RNA for Microarray Assays
2013
Cancer-related inflammation
2008 StandoutNature
Use of curcuminoids in a cohort of patients with oral lichen planus, an autoimmune disease
2012
Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism
2007
Liposome‐encapsulated curcumin
2005
Curcumin, a Molecule That Inhibits the Ca2+-ATPase of Sarcoplasmic Reticulum but Increases the Rate of Accumulation of Ca2+
2001
Curcumin Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis
2007
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
2003 StandoutNature
Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double‐blind placebo‐controlled cross‐over 4g study and an open‐label 8g extension study
2012
Inhibitory effects of [6]‐gingerol on PMA‐induced COX‐2 expression and activation of NF‐κB and p38 MAPK in mouse skin
2004
Comprehensive Integration of Single-Cell Data
2019 Standout
Curcumin modifies Apcmin apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apcmin mice
2001
Curcumin–phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats
2006
Autoxidative and Cyclooxygenase-2 Catalyzed Transformation of the Dietary Chemopreventive Agent Curcumin
2010
CLINICAL STUDIES WITH CURCUMIN
2007
MODULATION OF TRANSCRIPTION FACTORS BY CURCUMIN
2007
DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin
2001
Green Tea Polyphenol and Curcumin Inversely Regulate Human Involucrin Promoter Activity via Opposing Effects on CCAAT/Enhancer-binding Protein Function
2004
USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1
2013
Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer
2010
Tumour necrosis factor α: a potential target for the therapy of solid tumours
2003
Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat
2001
Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers
2007
Advances in Malignant Mesothelioma
2005 Standout
Curcumin: From ancient medicine to current clinical trials
2008 Standout
Parkinson's Disease
2003 Standout
Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine
2006
Sensitization of Taxol-induced Apoptosis by Curcumin Involves Down-regulation of Nuclear Factor-κB and the Serine/Threonine Kinase Akt and Is Independent of Tubulin Polymerization
2004
Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model
2010
Curcumin Suppresses Activation of NF-κB and AP-1 Induced by Phorbol Ester in Cultured Human Promyelocytic Leukemia Cells
2002
Curcumin Activates Defensive Genes and Protects Neurons Against Oxidative Stress
2006
The Gasotransmitter Hydrogen Sulfide Induces Nrf2-Target Genes by Inactivating the Keap1 Ubiquitin Ligase Substrate Adaptor Through Formation of a Disulfide Bond Between Cys-226 and Cys-613
2012
Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats.
2010
Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells
2003
Curcumin Bioavailability from Enriched Bread: The Effect of Microencapsulated Ingredients
2012
Bioavailability of Curcumin: Problems and Promises
2007 Standout
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
2010 Standout
Curcumin (Diferuloylmethane) Inhibits Receptor Activator of NF-κB Ligand-Induced NF-κB Activation in Osteoclast Precursors and Suppresses Osteoclastogenesis
2004
Betulinic Acid Suppresses Carcinogen-Induced NF-κB Activation Through Inhibition of IκBα Kinase and p65 Phosphorylation: Abrogation of Cyclooxygenase-2 and Matrix Metalloprotease-9
2003
Curcumin, a Dietary Component, Has Anticancer, Chemosensitization, and Radiosensitization Effects by Down-regulating the MDM2 Oncogene through the PI3K/mTOR/ETS2 Pathway
2007
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
2008
Innovative Preparation of Curcumin for Improved Oral Bioavailability
2011
Heme Oxygenases in Cardiovascular Health and Disease
2016
Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice
2014
Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequentin vitro/in vivoevaluation
2008
Anticancer potential of curcumin: preclinical and clinical studies.
2003 Standout
Clinical utility of curcumin extract.
2013
Dietary Curcumin Significantly Improves Obesity-Associated Inflammation and Diabetes in Mouse Models of Diabesity
2008
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Curcumin, a golden spice with a low bioavailability
2015
Effect of Different Curcuminoid Supplement Dosages on Total In Vivo Antioxidant Capacity and Cholesterol Levels of Healthy Human Subjects
2011
Curcumin Inhibits Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cell Function and Injury-Induced Neointima Formation
2005
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Curcumin inhibits telomerase activity in human cancer cell lines
2006
Nuclear factor–κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis
2003
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration—A Clinical Pilot Study Including Assessment of Patient Acceptability
2012
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Lipid‐Lowering Effects of Curcumin in Patients with Metabolic Syndrome: A Randomized, Double‐Blind, Placebo‐Controlled Trial
2014
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers
2013
Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer.
2002
Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine.
2002
Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects
2008
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Curcumin Differs from Tetrahydrocurcumin for Molecular Targets, Signaling Pathways and Cellular Responses
2014
EXPERIMENTAL LASER PHOTOCOAGULATION.
1964
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.
2002
Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.
2001
Metabolism and Anticancer Activity of the Curcumin Analogue, Dimethoxycurcumin
2007
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Advances in Nanotechnology-Based Delivery Systems for Curcumin
2012
Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-κB-dependent genes
2003
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction
2013
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis
2003
Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
2003
Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels.
2001
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma
2004
Heme-Containing Oxygenases
1996 Standout
Degradation of Curcumin: From Mechanism to Biological Implications
2015
Adjuvant Therapy with Bioavailability‐Boosted Curcuminoids Suppresses Systemic Inflammation and Improves Quality of Life in Patients with Solid Tumors: A Randomized Double‐Blind Placebo‐Controlled Trial
2014
Metabolism of Curcuminoids in Tissue Slices and Subcellular Fractions from Rat Liver
2006
Curcuminoids Form Reactive Glucuronides In Vitro
2006
Mechanisms of Pulsed Laser Ablation of Biological Tissues
2003 Standout
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway
2006
Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models
2004
Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy.
1988
Interplay between MRP Inhibition and Metabolism of MRP Inhibitors: The Case of Curcumin
2003
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-κB Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice
2005
Curcumin Suppresses Janus Kinase-STAT Inflammatory Signaling through Activation of Src Homology 2 Domain-Containing Tyrosine Phosphatase 2 in Brain Microglia
2003
Combination Treatment With Curcumin and Quercetin of Adenomas in Familial Adenomatous Polyposis
2006
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
2003 StandoutScience
From chemoprevention to chemotherapy: common targets and common goals
2004
Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture.
2003
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Biological Relevance of Adduct Detection to the Chemoprevention of Cancer
2004
Elucidation of Anti-allergic Activities of Curcumin-Related Compounds with a Special Reference to Their Anti-oxidative Activities
2005
Works of Simon Plummer being referenced
Induction of 8-hydroxydeoxyguanosine in isolated DNA and HeLa cells exposed to fecapentaene-12: evidence for the involvement of prostaglandin H synthase and iron
1994
Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex
1999
Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1–NRF2 pathway, and not the BACH1–NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds
2009
Blocking and suppressing mechanisms of chemoprevention by dietary constituents
2000
Oxidation and genotoxicity of fecapentaene-12 are potentiated by prostaglandin H synthase
1995
Time-Dependent and Compartment-Specific Effects of In Utero Exposure to Di(n-butyl) Phthalate on Gene/Protein Expression in the Fetal Rat Testis as Revealed by Transcription Profiling and Laser Capture Microdissection
2007
Modulation of signal-transduction pathways by chemopreventive agents
2000
Fecapentaene-12 causes DNA damage and mutations in human cells
1986
Phase I Clinical Trial of Oral Curcumin
2004
Is the activation of aflatoxin B1 catalysed by the same form of cytochrome P-450 as that 4-hydroxylating debrisoquine in rat and/or man?
1986
Cyclooxygenase-2 expression is a novel prognostic factor in malignant mesothelioma.
2002
Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
2001
Ha‐ras and β‐catenin oncoproteins orchestrate metabolic programs in mouse liver tumors
2014
Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents.
2001
Genotoxicity of fecapentaene-12 in bacterial and mammalian cell assay systems
1987
Suppression of tumour development by substances derived from the diet—mechanisms and clinical implications
1998